Search Results 731-740 of 18897 for creatine

1. Daratumumab to Treat Active Lupus Nephritis - Mayo Clinic

   ... creatinine. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...

2. GS-0976 In Adults With Nonalcoholic Steatohepatitis - Mayo Clinic

   Creatinine Clearance (CLcr ) as calculated by the Cockcroft-Gault equation ≥ 60 ml/min. Exclusion Criteria: Pregnant or lactating females; Alanine ...

3. Testing Teclistamab (TECVAYLI) In Combination With Iberdomide For Hard-to-Treat Multiple Myeloma - Mayo Clinic

   * Spot urine (albumin/creatine ratio) ≤ 500mg/g (56 mg/mmol) OR urine ... creatinine ratio (spot urine from first void) ( ≤ 28 days prior to ...

4. A Study to Evaluate Durvalumab plus Topotecan or Lurbinectedin in Patients with Small Cell Lung Cancer - Mayo Clinic

   Creatinine OR glomerular filtration rate (GFR) ≤ 1.5 x ULN OR GFR > 60 mL/min for patients with creatinine > 1.5 x ULN (obtained ≤ 15 days prior to ...

5. A Study to Determine Serum and Urine Reference Ranges in Patients with Normal Renal Function Being Administered Gadobutrol for an Enhanced Magnetic Resonance Imaging (MRI) - Mayo Clinic

   Serum creatinine <1.4 mg/dL; or; Glomerular filtration rate; ≥60 mL/min. No gadolinium-enhanced MRI in last 6 months. Scheduled to undergo a gadobutrol ...

6. Cyclophosphamide, Ixazomib, and Dexamethasone in Treating Patients With Previously Untreated Symptomatic Multiple Myeloma - Mayo Clinic

   Participation eligibility · Calculated creatinine clearance (using Cockcroft-Gault equation) ≥ 30 mL/min · Absolute neutrophil count (ANC) ≥ 1000/mm^3 · Platelet ...

7. CJNJ-67652000 And Prednisone For The Treatment Of Men With Metastatic Castration-Resistant Prostate Cancer And SPOP Gene Mutations - Mayo Clinic

   ... creatinine in mg/dL). Creatinine clearance for females = (140 - age)(weight in kg)(0.85) (72)(serum creatinine in mg/dL). Male patients who are committed to ...

8. Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1 - Mayo Clinic

   Renal: Creatinine > 1.5x ULN; Other: INR (prothrombin time ratio) or partial thromboplastin time (PTT) >1.5 x ULN. History of other cancer within 3 years ...

9. Diagnostic Utility of F-18 Florbetapir PET/MR in Peripheral Nerve Amyloidosis - Mayo Clinic

   Elevated creatinine levels; Seizures; Asthma; Hemolytic anemia; Claustrophobia; BMI over 45. Participating Mayo Clinic locations. Study statuses change often ...

10. A Study of Using Bortezomib and Combination Chemotherapy in Treating Children with Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma - Mayo Clinic

    Participation eligibility · Patients must have a performance status corresponding to Eastern Cooperative Oncology Group (ECOG) scores of 0, 1 or 2 · Creatinine ...